REVH

REVH

Revolution Healthcare Acquisition Corp.

Print
Follow
SPAC Target Focus
Healthcare & Medical
Expected Close Date
March 17, 2023
IPO Date
2021-03-17
IPO Size(M)
$ 550M
Underwriters
Morgan Stanley

Management

Jeff Leiden (Exec Chairman/Fmr CEO, Vertex Pharmaceuticals; Fmr COO, Abbott Laboratories), Robert Nelsen (Co-founder/Managing Director, ARCH), Jennifer Schneider (Fmr Pres/Chief Medical Officer, Livongo Health), Hemant Taneja (Managing Director, General Catalyst)

Management Team / Advisory Board Bios

Jeff Leiden (Exec Chairman/Fmr CEO, Vertex Pharmaceuticals; Fmr COO, Abbott Laboratories), Robert Nelsen (Co-founder/Managing Director, ARCH), Jennifer Schneider (Fmr Pres/Chief Medical Officer, Livongo Health), Hemant Taneja (Managing Director, General Catalyst)
Amount Raised : $0
Reveal the Score by Voting
_
0
Business Idea
Business Traction
Management Team
Valuation

Research Reports

No reports have been submitted

Become a Reporter

0 Comments